Helen Sabzevari - 24 Mar 2023 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role
President and CEO, Director
Signature
/s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact
Issuer symbol
PGEN
Transactions as of
24 Mar 2023
Net transactions value
$0
Form type
4
Filing time
28 Mar 2023, 21:08:19 UTC
Previous filing
30 Jan 2023
Next filing
02 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGEN Common Stock Options Exercise +283,173 +30% 1,220,786 24 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGEN Restricted Stock Units Award $0 +849,520 $0.000000 849,520 24 Mar 2023 Common Stock 849,520 Direct F1, F2
transaction PGEN Restricted Stock Units Options Exercise $0 -283,173 -33% $0.000000 566,347 24 Mar 2023 Common Stock 283,173 Direct F1, F3
transaction PGEN Option to Purchase Common Stock (Right to Buy) Award $0 +369,596 $0.000000 369,596 24 Mar 2023 Common Stock 369,596 $0.9600 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
F2 1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023.
F3 Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately.